Vatalanib, a tyrosine kinase inhibitor, decreases hepatic fibrosis and sinusoidal capillarization in CCl(4)-induced fibrotic mice

Among the various consequence arising from lung injury, hepatic fibrosis is the most severe. Decreasing the effects of hepatic fibrosis remains one of the primary therapeutic challenges in hepatology. Dysfunction of hepatic sinusoidal endothelial cells is considered to be one of the initial events t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Ling-Jian, Li, Hao, Du, Ya-Ju, Pei, Feng-Hua, Hu, Ying, Zhao, Liao-Liao, Chen, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428398/
https://www.ncbi.nlm.nih.gov/pubmed/28447731
http://dx.doi.org/10.3892/mmr.2017.6325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428398/
https://www.ncbi.nlm.nih.gov/pubmed/28447731
http://dx.doi.org/10.3892/mmr.2017.6325

Ejemplares similares